Article Versions Notes

Alomair BM, Al-kuraishy HM, Al-Gareeb AI, Al-Hamash SM, De Waard M, Sabatier J-M, Saad HM, El-Saber Batiha G. Montelukast and Acute Coronary Syndrome: The Endowed Drug. Pharmaceuticals. 2022; 15(9):1147. https://doi.org/10.3390/ph15091147

Alomair, Basil Mohammed, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Sadiq M. Al-Hamash, Michel De Waard, Jean-Marc Sabatier, Hebatallah M. Saad, and Gaber El-Saber Batiha. 2022. "Montelukast and Acute Coronary Syndrome: The Endowed Drug" Pharmaceuticals 15, no. 9: 1147. https://doi.org/10.3390/ph15091147

Alomair, B. M., Al-kuraishy, H. M., Al-Gareeb, A. I., Al-Hamash, S. M., De Waard, M., Sabatier, J.-M., Saad, H. M., & El-Saber Batiha, G. (2022). Montelukast and Acute Coronary Syndrome: The Endowed Drug. Pharmaceuticals, 15(9), 1147. https://doi.org/10.3390/ph15091147